Outside of its pain-relieving results, conolidine has demonstrated a positive safety margin in preclinical toxicology assessments. In contrast to opioids, which regularly lead to respiratory depression at increased doses, conolidine has not generated indications of sizeable respiratory suppression. Moreover, behavioral assessments in murine products counsel an absence of drug-seeking https://williamk395csj0.idblogz.com/profile